• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book Apps
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » ConsumerLab.com: Guiding Patients Toward OTCs That Won’t Hurt Them

ConsumerLab.com: Guiding Patients Toward OTCs That Won’t Hurt Them

July 1, 2017
Richard Gardiner, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Richard Gardiner, MD Psychiatrist in private practice in Potter Valley, CA Dr. Gardiner has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

“It’s rare that my patients don’t at some point or another try an over-the-counter sleep aid, anxiety preparation, or antidepressant supplement,” says TCPR board member Richard Gardiner, MD, who practices psychiatry in Mendocino County, California. While supplements may be helpful—we covered this topic in TCPR’s November/December 2016 issue—the FDA does not test them for purity or efficacy. For this reason, Gardiner often steers patients to ConsumerLab.com (CL).

CL was started by physician Tod Cooperman in 1999 along with FDA scientist Dr. William Obermeyer. The company’s mission is “to identify the best-quality health and nutritional products through independent testing.” CL purchases health products from retail stores and submits them to third-party laboratories. The goal is to compare different branded versions of a product, then report which ones passed—and which ones failed—the company’s quality tests. To date, CL has tested more than 4,400 products, including everything from black cohosh to valerian. In its report on valerian, for instance, it points out that two of the products tested contained lead, and that the amount of active ingredient in the supplements varied by more than 7-fold. Similar to Consumer Reports, CL publishes tables reviewing the major brands side by side, comparing the accuracy of the labels as well as relative cost.

Dr. Gardiner recommends the site to patients to “try to stop them from hurting themselves with mislabeled products or wasting their money” and to help determine whether a supplement might interfere with a medication he is prescribing. “If someone’s taking valerian and I’m giving them a sleeping pill and they’re now sleeping all day, is it because they are overdosing?” he asks as an example. The information on the site helps him and his patients find out.

A 12-month subscription to CL costs $39; a 24-month subscription costs $64. You can also sign up for a free one-day trial to read some sample reviews.
General Psychiatry
KEYWORDS anxiety_disorder natural_medications practice-tools-and-tips
    Richard Gardiner, MD

    More from this author
    www.thecarlatreport.com
    Issue Date: July 1, 2017
    SUBSCRIBE NOW
    Table Of Contents
    CME Post-Test - Antidepressants, TCPR, July/August 2017
    Beginning Antidepressant Treatment: A Recommended Approach
    When First-Line Depression Treatments Don’t Cut It: Newer Antidepressants and Sometimes, Antipsychotics
    When Depression Meds Fail, Transcranial Magnetic Stimulation Might Be Plan B
    ConsumerLab.com: Guiding Patients Toward OTCs That Won’t Hurt Them
    NeuroStar’s Latest TMS System: 19 Minutes Is the New 40
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2635946985.jpg
      General Psychiatry

      AI in Practice

      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.